DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DAVALINTIDE ACETATE
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
DAVALINTIDE ACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4QM48103XT
Molecule Type:
Protein
Molecular Formula:
C154H252N50O51S2
Molecular Weight:
3684.14
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NIMACIMAB
2
Antibody
Investigational
Unknown
Unknown
Gastroparesis
Cannabinoid CB1 receptor negative allosteric modulator
NIMACIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
85TS31SOL3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RECIFERCEPT
2
Protein
Investigational
Unknown
Unknown
Achondroplasia
Unknown
RECIFERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLASMIN (HUMAN)
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PLASMIN (HUMAN)
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-501
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NT-501
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALG-1001
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
ALG-1001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L19TNFA
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Fibronectin binding agent
L19TNFA
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-0976
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GS-0976
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YM-543
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
YM-543
×
Maximum Phase:
2
First Approval:
None
UNII:
KA83KI0EO9
Molecule Type:
Small molecule
Molecular Formula:
C28H37NO7
Molecular Weight:
499.6
AlogP:
1.6
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
4.0
Source:
TYROSINASE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TYROSINASE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-EFLORNITHINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-EFLORNITHINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
UO07O10TCJ
Molecule Type:
Small molecule
Molecular Formula:
C6H13ClF2N2O2
Molecular Weight:
218.63
AlogP:
-0.23
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BMX-010
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Acne Vulgaris; Dermatitis, Atopic; Psoriasis; Rosacea
Unknown
BMX-010
×
Maximum Phase:
2
First Approval:
None
UNII:
BN93L2NT5I
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONO-2333MS
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Corticotropin releasing factor receptor 1 antagonist
ONO-2333MS
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASUNERCEPT
2
Protein
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Glioblastoma; Severe Acute Respiratory Syndrome
Tumor necrosis factor ligand superfamily member 6 binding agent
ASUNERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
F333OQQ9UV
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVALEUKIN ALFA
2
Protein
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Graft vs Host Disease; Lupus Erythematosus, Systemic
Unknown
EFAVALEUKIN ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
YNH9K62UXU
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RED CLOVER
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RED CLOVER
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELPAZOLID
2
Small molecule
Investigational
Unknown
Unknown
Tuberculosis, Pulmonary
Bacterial 70S ribosome inhibitor
DELPAZOLID
×
Maximum Phase:
2
First Approval:
None
UNII:
43EP6XV33E
Molecule Type:
Small molecule
Molecular Formula:
C14H17FN4O3
Molecular Weight:
308.31
AlogP:
0.84
PSA:
68.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
3F8
2
Antibody
Investigational
Unknown
Unknown
Neuroblastoma
Disialoganglioside GD2 other
3F8
×
Maximum Phase:
2
First Approval:
None
UNII:
3GFS72WN4M
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONFEKAFUSP ALFA
2
Protein
Investigational
Unknown
Unknown
Glioblastoma; Glioma; Sarcoma
Unknown
ONFEKAFUSP ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
6HXC0O6JMV
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FADOLMIDINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Adrenergic receptor alpha-2 agonist
FADOLMIDINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
S3709T25V6
Molecule Type:
Small molecule
Molecular Formula:
C13H15ClN2O
Molecular Weight:
250.73
AlogP:
2.39
PSA:
48.91
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IBIPINABANT
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Cannabinoid CB1 receptor antagonist
IBIPINABANT
×
Maximum Phase:
2
First Approval:
None
UNII:
O5CSC6WH1T
Molecule Type:
Small molecule
Molecular Formula:
C23H20Cl2N4O2S
Molecular Weight:
487.41
AlogP:
4.76
PSA:
74.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK-679586A
2
Antibody
Investigational
Unknown
Unknown
Asthma
Unknown
GSK-679586A
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TNX-650
2
Antibody
Investigational
Unknown
Unknown
Hodgkin Disease
Interleukin-13 inhibitor
TNX-650
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CORTODOXONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CORTODOXONE
×
Maximum Phase:
2
First Approval:
None
UNII:
WDT5SLP0HQ
Molecule Type:
Small molecule
Molecular Formula:
C21H30O4
Molecular Weight:
346.47
AlogP:
2.81
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
MK-0812
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Multiple Sclerosis, Relapsing-Remitting
C-C chemokine receptor type 2 antagonist
MK-0812
×
Maximum Phase:
2
First Approval:
None
UNII:
P3LKY4ZL5O
Molecule Type:
Small molecule
Molecular Formula:
C24H36F3N3O2
Molecular Weight:
455.57
AlogP:
4.05
PSA:
46.62
HBD:
1.0
HBA:
#RotB:
6.0
Source:
SUVECALTAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Essential Tremor; Schizophrenia
Voltage-gated T-type calcium channel modulator
SUVECALTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
MIA4WMP8QN
Molecule Type:
Small molecule
Molecular Formula:
C20H23F3N2O2
Molecular Weight:
380.41
AlogP:
4.57
PSA:
51.22
HBD:
1.0
HBA:
#RotB:
7.0
Source:
MEZAGITAMAB
2
Antibody
Investigational
Unknown
Unknown
Autoimmune Diseases; Lupus Erythematosus, Systemic; Multiple Myeloma; Myasthenia Gravis; Purpura, Thrombocytopenic, Idiopathic
Lymphocyte differentiation antigen CD38 binding agent
MEZAGITAMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
0XMR8L9LOL
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
7-METHYLXANTHINE
2
Small molecule
Investigational
Unknown
Unknown
Myopia
Unknown
7-METHYLXANTHINE
×
Maximum Phase:
2
First Approval:
None
UNII:
E9M81NJM6G
Molecule Type:
Small molecule
Molecular Formula:
C6H6N4O2
Molecular Weight:
166.14
AlogP:
-0.23
PSA:
84.06
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DEXTRAN SULFATE SODIUM (5000 MW)
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1
Unknown
DEXTRAN SULFATE SODIUM (5000 MW)
×
Maximum Phase:
2
First Approval:
None
UNII:
V5LWP0C2L5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZX-100
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZX-100
×
Maximum Phase:
2
First Approval:
None
UNII:
0HT093MD6R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-DOS47
2
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms; Adenocarcinoma of Lung
Unknown
L-DOS47
×
Maximum Phase:
2
First Approval:
None
UNII:
95E1ZQM329
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DABUZALGRON
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Alpha-1a adrenergic receptor partial agonist
DABUZALGRON
×
Maximum Phase:
2
First Approval:
None
UNII:
LGX4GZ74WO
Molecule Type:
Small molecule
Molecular Formula:
C12H16ClN3O3S
Molecular Weight:
317.8
AlogP:
1.4
PSA:
79.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EXBIVIRUMAB
2
Antibody
Investigational
Unknown
Unknown
Hepatitis B, Chronic
Unknown
EXBIVIRUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
5Q374M1S1P
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEVIRIMAT
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
BEVIRIMAT
×
Maximum Phase:
2
First Approval:
None
UNII:
S125DW66N8
Molecule Type:
Small molecule
Molecular Formula:
C36H56O6
Molecular Weight:
584.84
AlogP:
8.14
PSA:
100.9
HBD:
2.0
HBA:
#RotB:
6.0
Source:
GZD-824 DIMESYLATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GZD-824 DIMESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
139
140
141
142
143
144
145
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA